MyDrHank Review
Semaglutide & tirzepatide GLP-1 weight-loss telehealth · Independently scored 7/10
Best for: an oral route if you will not self-inject
MyDrHank falls below our bar on medical oversight. Read the breakdown below before you give it money.
Covered by the monthly price
Medication
Not stated
Clinician visits
Not stated
Shipping
Not stated
Lab work
Not stated
Coaching
Not stated
No insurance needed · Vetted by our editors
This entry covers the erectile-dysfunction side of MyDrHank, whose legal name is Dr. Hank, LLC. Four products sit on the list: sildenafil in generic form, tadalafil both generic and daily, and MDH Drive, which dissolves rapidly and pairs sildenafil with tadalafil. Every case gets reviewed online by providers holding U.S. licenses, and three partner pharmacies are named. Plans are itemized at one, three and six months, the cheapest being $25/mo for generic sildenafil, with free shipping and nothing to commit to.
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
Vetted alternatives to MyDrHank
Editorial score · methodology
Editorial score · methodology
Editorial score · methodology
MyDrHank at a glance
- Type
- GLP-1 telehealth provider
- Medications
- Semaglutide, Tirzepatide
- Starting price
- $25/mo (Unchanged.)
- FDA status
- No FDA warning letter on record
How MyDrHank scores
Six columns, each one computed from something MyDrHank has published rather than from an opinion we formed: what it charges, which molecules it will dispense, what its record shows, and what the monthly figure actually buys. Where it publishes nothing, that absence is what gets scored. Every seller in the register goes through the same six columns.
Value25%
5.8/10$240/month is 10% below the register median of $267 for compounded tirzepatide.
Effectiveness25%
10.0/10Dispenses semaglutide and tirzepatide, compounded only. Anchored to SURMOUNT-1 (tirzepatide, -20.9%) and STEP 1 (semaglutide, -14.9%).
User Experience15%
8.0/10On the seller's own pages, a price is published before the questionnaire starts.
Trust & Safety15%
5.5/10does not name a dispensing pharmacy; shows a price before asking for health information. Our verification confidence is low.
Accessibility10%
5.0/10Publishes no list of states served, so coverage cannot be confirmed either way. Capped at the midpoint — this measures disclosure, not reach.
Support10%
5.0/10States too little about what the monthly cost covers to score the bundle. Held at the midpoint rather than assumed.
A seller that will not show a price before an intake loses points on Value and carries that note in its review. Withholding the number is itself a finding. How we score →
What we checked on MyDrHank
Last checked July 2026- Re-read the price on file across 14 dose or plan tiers
- Searched our FDA enforcement register for this operator
Price, availability, and compliance here are read off the seller's own pages and off primary regulatory records, named in the sources below. Editorial confidence in this data: low.
What signing up with MyDrHank involves
Assembled from this seller’s entry in the register — the price record, the state list, the dispensing pharmacy where one is named, and what the monthly figure covers. It describes what a reader can expect to meet on the way to a prescription, and what is missing from the seller’s own disclosures. It is not a clinical judgment and not a prescribing decision.
- 1MyDrHank publishes a price on its own site before asking anything about you. You can compare it against this register without starting a questionnaire.
- 2The intake is a written questionnaire. No live video visit or baseline bloodwork is recorded as required.
- 3MyDrHank does not say which pharmacy dispenses the medication. That is common here and it means you cannot check the pharmacy's record before you buy.
- Cheapest standing monthly prices on record: semaglutide $171, tirzepatide $240. Membership fees, first-month rates and insured copays are excluded from those figures.
- No state list is published, so whether MyDrHank serves your state cannot be confirmed from its site.
- The medication is compounded, so it is not an FDA-approved product and has not been reviewed by the agency for safety, effectiveness or manufacturing quality.
GLP-1 medications MyDrHank offers
Each one has its own guide: how the molecule works, the dosing schedule, the side effects that show up in practice, and what the trials actually measured.
Pricing
Prices re-verified
Unchanged vs entry. Tiers: 6-Month $150 total/$25 per mo; 3-Month $90/$30; 1-Month $35. mg strength still not disclosed pre-purchase.
Unchanged.
Unchanged. Tiers: 6-Month $180/$30; 3-Month $105/$35; 1-Month $45.
Unchanged.
Unchanged. Tiers: 6-Month $210/$35; 3-Month $120/$40; 1-Month $49.
Unchanged.
Unchanged. Tiers: 6-Month $270/$45; 3-Month $150/$50; 1-Month $59.
Unchanged.
NEW itemized tiers: Monthly $249; Quarterly $635/$212; 6-Month $1,143/$190; Yearly $2,057/$171. A 'Semaglutide Tablets' page variant lists Monthly total $399/perMonth $329 (site-side inconsistency), Yearly $3,297/$275.
Matches site-wide 'Plans start at $171/mo for compounded semaglutide' disclaimer.
Tiers: Monthly $259; Quarterly $660/$220; 6-Month $1,189/$198; Yearly $2,140/$178. Above the $175 sema median unless a long commitment is taken.
Tiers: Monthly $349; Quarterly $890/$297; 6-Month $1,602/$267; Yearly $2,883/$240. Above the $249 tirz median month-to-month; only the yearly commit dips below. Their own disclaimer claims 'start at $200/mo for compounded tirzepatide' — no $200 tier exists on any card (internal inconsistency).
Check the price yourself before you pay
Every figure here was read off MyDrHank's own checkout on the date shown. Sellers move prices without announcing it, and promotional rates lapse, so confirm the standing cost on their site before committing.
In its favor
- Semaglutide at $171 a month, within the normal band around this register's $199 median for the same drug and form
- Publishes a price on its own site before the medical questionnaire, so it can be compared without handing over health information
- No FDA warning letter matched this operator when we searched our enforcement register
- Both oral and injectable options are on record, so the format is a choice rather than a condition
Against it
- No state list is on record here, so whether it serves your state cannot be confirmed from this page
- No dispensing pharmacy is named in our record, so its accreditation cannot be looked up from here
- Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality
What MyDrHank charges
The standing price at MyDrHank is $25/month. That sits at the affordable end of what we track.
- Oral sildenafil — $35/month
- Oral sildenafil — $25/month
- Oral tadalafil — $45/month
- Oral tadalafil — $30/month
- Oral tadalafil (low-dose daily) — $49/month
- Oral tadalafil (low-dose daily) — $35/month
Across the GLP-1 providers in our register the median standing price is about $169/month, so MyDrHank is genuinely under the middle rather than merely advertising that it is.
What MyDrHank dispenses
MyDrHank prescribes semaglutide (approved as Wegovy and Ozempic) and tirzepatide (approved as Zepbound and Mounjaro). Between them these are the two best-evidenced weight-loss molecules currently on the market. These are compounded preparations from a licensed pharmacy rather than approved pens, which is where the lower price comes from. A compounded drug is not FDA-approved as a finished product — the specific preparation has not been reviewed for safety, efficacy or manufacturing quality.
A needle-free oral option is genuinely uncommon and is the reason some readers will look at MyDrHank at all. Set expectations on the evidence, though: the published weight-loss trials for these molecules used injections. Oral and sublingual delivery of peptides is far less studied, so treat it as a route that solves the needle problem rather than as a demonstrated equal to the shot.
What we could verify
MyDrHank publishes little that can be checked from outside an intake. We searched the federal warning-letter record for this operator and came back with nothing. Because the medication is compounded and no dispensing pharmacy is named publicly, the single most useful question to ask at intake is which licensed pharmacy fills the prescription. A seller that will not answer that has told you something. How we weigh oversight, disclosure and price evidence is set out in our scoring methodology.
Who should look elsewhere
- You want the FDA-approved pen specifically. Nothing here is the approved finished product.
- You need to bill insurance. Like most of this market, this is cash-pay.
It fits if
- the lowest standing monthly cost is what you are solving for
- injections are the thing keeping you from starting
Our read
MyDrHank competes on price and does it without an obvious sacrifice elsewhere: $25/month, no warning letter on file, and access that is not unusually restricted. CoreAge Rx is the nearest comparison we track, and worth reading alongside this.
The Bottom Line
MyDrHank falls below our bar on medical oversight. Read the breakdown below before you give it money.
Before you pay MyDrHank
Starting at $25/month. Check today's price, then book the free consultation.
Where MyDrHank is the wrong choice
No seller in this register suits every reader, and saying otherwise would be the easiest way to sell one. On these four counts another entry does better.
Frequently Asked Questions
Glossary
The words sellers use, defined. Tap any term.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources
Cited across this MyDrHank review: primary regulatory filings, and peer-reviewed studies.
Sources & methodology — as of August 2026
- 1.GLP Watchdog — GLP-1 Pricing Index 2026 (our independent dataset)— GLP Watchdog.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
See MyDrHank's current pricing
Plans start at $25/month. The free consultation is where you learn whether you qualify, and what it costs today.